NewAmsterdam Pharma Company N.V. NAMS
19.57 USD -1.36 (-6.50%)
Nov 5, 2026, 10:31 AM EST
19.50 Day range 20.77
19.13 52-week range 42.21
- YTD
- -44.21%
- 1 year
- -48.68%
Analyst view
Price target (mean) 50.09 +156.0% upside
Now 19.57
- Target (low)
- 38.14
- Target (mean)
- 50.09
- Target (high)
- 59.47
Ratings (0m) 16 15 buy · 1 hold · 0 sell
- Strong buy3
- Buy12
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.39585 | -0.554 – -0.234 | -0.53267 | +25.7% | 13.42M | +49489.6% | 13 |
| Next quarter | -0.52875 | -0.638 – -0.459 | -0.33984 | -55.6% | 1.41M | -45.6% | 4 |
| Current year | -1.66 | -1.87 – -1.43 | -1.45 | -14.1% | 24.76M | +30.1% | 12 |
| Next year | -1.55 | -2.74 – 1.88 | -1.64 | +5.5% | 119.88M | +384.1% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 19, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 18, 2026 | Needham | Maintained | Buy | Buy |
| Jan 21, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 16, 2025 | Stifel | Maintained | Buy | Buy |
| Dec 2, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 6, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 5, 2025 | Needham | Maintained | Buy | Buy |
| Oct 17, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 25, 2025 | Wells Fargo | Initiated | — | Overweight |
| Aug 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 17, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Jun 17, 2025 | Citigroup | Initiated | — | Buy |
| Jun 12, 2025 | Needham | Reiterated | Buy | Buy |
| Jun 10, 2025 | Stifel | Initiated | — | Buy |
| May 8, 2025 | Needham | Maintained | Buy | Buy |
| Apr 8, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 27, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Feb 27, 2025 | Needham | Maintained | Buy | Buy |
| Jan 28, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 24, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 30, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 11, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Dec 5, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 21, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 11, 2024 | Needham | Reiterated | Buy | Buy |